Published 9 January 2020 Anna Häger Glenngård and Sixten Borg. (Photo: Louise Larsson) The risk of experiencing financial difficulties due to medical care costs is relatively small in Sweden. This is revealed in a recent report from the World Health Organization, where researchers from Lund University have investigated the extent to which Swedish households are financially affected by using the he

https://www.medicine.lu.se/article/who-report-healthcare-sweden-among-most-affordable-europe - 2025-05-01

Published 9 January 2020 Merab Kokaia and My Andersson (Photo: Tove Smeds) Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy. One challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain tissue for experiments. For t

https://www.medicine.lu.se/article/peptide-reduced-epileptic-seizures-human-brain-tissue - 2025-05-01

Published 9 January 2020 Madelene Å Andersson, Sven Kjellström, Jitka Petrlova, Artur Schmidtchen, Ann-Charlotte Strömdahl, Manoj Puthia. (Photo: Olle Dahlbäck) Researchers at Lund University in Sweden have developed a new hydrogel based on the body’s natural peptide defense. It has been shown to prevent and treat infections in wounds. The formulation kills multi-resistant bacteria, something that

https://www.medicine.lu.se/article/next-generation-wound-gel-treats-and-prevents-infections - 2025-05-01

By tove [dot] gilvad [at] med [dot] lu [dot] se (Tove Gilvad) - published 23 January 2020 European complementologists have joined forces and created CORVOS. A highly coordinated and innovative research and training program for early stage researchers in immunology and infectious diseases. Lund University is a part of the initiative. Anna Blom, Professor at Lund University, participating in the COR

https://www.medicine.lu.se/article/corvos-european-joint-doctorate-programme-immunology - 2025-05-01

Published 29 January 2020 Immunofluorescence analysis of a melanoma tumor showing that B cells in B cell clusters express CXCR5, a marker for tertiary lymphoid structures. (Source: Göran Jönsson) Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The

https://www.medicine.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-05-01

Published 3 February 2020 In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the

https://www.medicine.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-05-01

Published 4 February 2020 Up to 45 per cent of all deaths in industrialised countries are caused by fibrotic diseases. Through boundary-crossing research and the high-tech MAX IV laboratory in Lund it is possible to increase the knowledge of fibrosis – bringing a cure closer. ”Fibrosis is a form of scarring that can affect all types of damaged organs and tissues in the body. When this process take

https://www.medicine.lu.se/article/high-tech-collaboration-supports-fibrosis-research - 2025-05-01

Published 6 February 2020 Within the framework of an international study, Lund University and Skåne University Hospital have started treating patients with hemophilia with gene therapy, something that began in January this year. The hope is that the new treatment will significantly simplify everyday life for those with severe hemophilia. Hemophilia is a genetic disease where the body does not prod

https://www.medicine.lu.se/article/hemophilia-being-treated-gene-therapy - 2025-05-01

Published 6 February 2020 The Leif C. Groop Award for Outstanding Diabetes Research has been awarded to Niels Grarup of the Novo Nordisk Foundation Centre for Basic Metabolic Research at the University of Copenhagen. His research has shown that there is a genetic explanation for the increase in type 2 diabetes in Greenland. The prize, worth SEK 100 000, is donated by the pharmaceutical company Nov

https://www.medicine.lu.se/article/award-research-increased-risk-type-2-diabetes-greenland - 2025-05-01

Published 6 February 2020 In their quest to find new and better methods to make cancer cells more susceptible to treatment, Karin Lindkvist and her research group at Lund University in Sweden are looking into the world of molecules, using the X-rays at the MAX IV laboratory. The researchers believe that limiting the cells' access to sugar will make cancer cells more sensitive to treatment. Many of

https://www.medicine.lu.se/article/researchers-believe-sugar-and-obesity-can-make-cancer-cells-more-difficult-kill - 2025-05-01

Published 19 February 2020 Esther González-Padilla. The more sugar we eat, the less vitamins and minerals we consume, new findings from Lund University in Sweden show. However, the researchers behind the study do not believe that their results alone are enough to make changes to current dietary recommendations. High sugar intake has been associated with numerous diseases and conditions such as poo

https://www.medicine.lu.se/article/more-sugar-less-vitamins-we-eat-study-shows - 2025-05-01

Published 19 February 2020 Martin Magnusson (Photo: Kennet Ruona) A new epidemiological study from Lund University and Skåne University Hospital in Sweden shows that there is a connection between high levels of the gastrointestinal hormone GIP in the blood, and an elevated risk of cardiovascular disease. It is well known that the intestinal hormones GIP and GLP-1 are important for insulin producti

https://www.medicine.lu.se/article/gut-hormone-can-increase-risk-cardiovascular-disease - 2025-05-01

Published 26 February 2020 Diabetes, cardiovascular disease, Parkinson's and Alzheimer's disease make up the world’s most common diseases. A new biobank at Lund University in Sweden - the largest of its kind - with stem cells from both those affected and healthy individuals, will contribute to an increased understanding of how these diseases arise. “The goal is for researchers to be able to develo

https://www.medicine.lu.se/article/worlds-largest-stem-cell-biobank-launched - 2025-05-01

By david [dot] ekberg [at] med [dot] lu [dot] se (David Ekberg) - published 2 March 2020 As the body ages, there is a general loss of function in all organs. Among other things this leads to declining renal function and osteoporosis among the elderly, the latter to a greater extent among women. A new doctoral dissertation from Lund University illuminates women’s aging and investigates the relation

https://www.medicine.lu.se/article/kidney-function-and-osteoporosis-elderly - 2025-05-01

Published 2 March 2020 How accessible are Swedish homes to the elderly? Pensioners, teachers and students all over Sweden will be helping researchers at the Centre for Ageing and Supportive Environments (CASE) at Lund University to find out in the ForskarFredag (Researchers’ Friday) 2020 mass experiment – the Housing Experiment. Professor Susanne Iwarsson, coordinator for CASE and head of the Acti

https://www.medicine.lu.se/article/out-tape-measure-first-time-sweden-mass-experiment-involving-elderly - 2025-05-01

Publicerad 16 april 2021 Pressmeddelande från Uppsala universitet: I år är det 100 år sedan insulinet upptäcktes. Diabetes som tidigare inneburit en säker död blev plötsligt behandlingsbart. Sedan dess har insulinläkemedlen och även metoderna för att mäta blodsocker förbättrats. I framtiden hoppas forskarna kunna bota sjukdomen med hjälp av stamceller. Om 10–15 år kan det vara fullt möjligt att tr

https://www.diabetesportalen.lu.se/artikel/diabetesbehandling-fran-insulin-till-transplantationer - 2025-05-01

Publicerad 20 april 2021 Risken för diabeteskomplikationer varierar kraftigt mellan olika individer. Några lever relativt friska med sjukdomen i flera decennier, andra drabbas betydligt snabbare och av allvarliga hälsoproblem. Enligt forskare är det de typ 2 diabetiker som fick sin diagnos tidigt, som har högt fasteblodsocker och stort midjemått. I en artikel i tidskriften Journal of Diabetes and

https://www.diabetesportalen.lu.se/artikel/storsta-riskerna-vid-typ-2-diabetes - 2025-05-01

Publicerad 27 april 2021 Personer med typ 2-diabetes har sämre muskelfunktion än friska personer. Nu har forskare sett att vid typ 2-diabetes har genen VPS39 stor betydelse för muskelfunktionen och muskelstamcellernas förmåga att bygga nya muskelceller. Det framkommer i en ny internationell studie ledd från Lunds universitet. Studien är publicerad i Nature Communications. – Hos personer med typ 2-

https://www.diabetesportalen.lu.se/artikel/muskelgen-kopplas-till-typ-2-diabetes - 2025-05-01

Publicerad 27 april 2021 ”Diabetes är en underlig sjukdom”. Så sa en grekisk läkare för nästan 2 000 år sedan. Dagens diabetesforskare skulle kanske inte använda ordet underlig men fortfarande finns många angelägna frågor som väntar på ett svar. En av dem är varför den egna insulinproduktionen ganska snabbt helt slås ut hos de flesta nyinsjuknade i typ 1 diabetes men inte hos alla. De behåller en

https://www.diabetesportalen.lu.se/artikel/forsok-att-radda-kvarvarande-insulinproduktion - 2025-05-01

Publicerad 11 maj 2021 Pressmeddelande Dagens Diabetes. Professor Anders Tengholm vid Uppsala universitet har fått ett forskningsanslag på 2 000 000 kronor av Diabetes Wellness Sverige för sitt projekt ”Rap and Ras signalling in insulin secretion”. Vårt syfte på stiftelsen Diabetes Wellness Sverige är att öka allmänhetens kunskaper om diabetes och att ge olika typer av stöd till diabetiker i vänta

https://www.diabetesportalen.lu.se/artikel/forskningsanslag-insulinfrisattning - 2025-05-01